Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
deals
fda
6
×
life sciences
national blog main
boston blog main
national top stories
boston top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
startups
alnylam pharmaceuticals
boston
food and drug administration
medical devices
new york
novartis
raleigh-durham blog main
san diego blog main
san diego top stories
sanofi
abbvie
akouos
alex gorsky
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
amyotrophic lateral sclerosis (als)
anirvan ghosh
ashley mcevoy
astrazeneca
atrial fibrillation
auris health
autoimmune disorders
What
deal
6
×
drug
medicines
acquire
billion
cash
developer
disease
plans
startup
acquiring
acquisitions
adding
agreed
alternative
announced
atrial
auris
autoimmune
bio
boston
brings
building
builds
business
buy
candidate
ceo
cholesterol
collabs
company
company’s
compound
continues
covid
cryterion
daniel
device
established
expensive
Language
unset
Current search:
deal
×
biotech
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed